GUCY2F
Basic information
Region (hg38): X:109372906-109482086
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GUCY2F gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 56 | 63 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 56 | 6 | 5 |
Variants in GUCY2F
This is a list of pathogenic ClinVar variants found in the GUCY2F region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-109375930-G-A | not specified | Uncertain significance (Mar 03, 2025) | ||
X-109375978-C-A | not specified | Uncertain significance (Jul 02, 2024) | ||
X-109376080-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
X-109376083-C-G | not specified | Uncertain significance (Jan 07, 2025) | ||
X-109376127-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
X-109376145-A-C | not specified | Uncertain significance (Jul 16, 2024) | ||
X-109382137-C-G | not specified | Uncertain significance (Apr 22, 2022) | ||
X-109385274-C-A | not specified | Uncertain significance (Feb 13, 2024) | ||
X-109385279-G-A | not specified | Uncertain significance (Jul 27, 2024) | ||
X-109388491-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
X-109388528-G-T | not specified | Uncertain significance (Mar 21, 2023) | ||
X-109388529-C-T | not specified | Uncertain significance (Jan 16, 2025) | ||
X-109388560-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
X-109388601-C-A | not specified | Uncertain significance (Jun 26, 2024) | ||
X-109388626-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
X-109391951-G-A | Likely benign (Mar 01, 2023) | |||
X-109392020-A-C | not specified | Uncertain significance (Nov 09, 2022) | ||
X-109392035-T-C | Uncertain significance (Jun 07, 2018) | |||
X-109392045-C-G | not specified | Uncertain significance (May 31, 2023) | ||
X-109392087-G-C | not specified | Uncertain significance (Oct 05, 2023) | ||
X-109392891-C-T | Uncertain significance (-) | |||
X-109392922-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
X-109392925-T-G | not specified | Uncertain significance (Jan 04, 2024) | ||
X-109392955-C-T | not specified | Uncertain significance (Mar 07, 2023) | ||
X-109392956-G-A | not specified | Uncertain significance (Feb 07, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GUCY2F | protein_coding | protein_coding | ENST00000218006 | 18 | 109167 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.06e-13 | 0.694 | 125627 | 43 | 76 | 125746 | 0.000473 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.205 | 427 | 415 | 1.03 | 0.0000302 | 7258 |
Missense in Polyphen | 134 | 132.94 | 1.008 | 2668 | ||
Synonymous | -1.73 | 178 | 151 | 1.18 | 0.0000108 | 2175 |
Loss of Function | 1.71 | 26 | 37.3 | 0.697 | 0.00000301 | 613 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00140 | 0.00122 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000655 | 0.000489 |
Finnish | 0.000690 | 0.000508 |
European (Non-Finnish) | 0.000818 | 0.000571 |
Middle Eastern | 0.000655 | 0.000489 |
South Asian | 0.000426 | 0.000261 |
Other | 0.000223 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probably plays a specific functional role in the rods and/or cones of photoreceptors. It may be the enzyme involved in the resynthesis of cGMP required for recovery of the dark state after phototransduction.;
- Pathway
- Purine metabolism - Homo sapiens (human);Phototransduction - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Purine metabolism;actions of nitric oxide in the heart;Purine nucleotides nucleosides metabolism;Visual signal transduction: Rods;G alpha (i) signalling events;Inactivation, recovery and regulation of the phototransduction cascade;The phototransduction cascade;Visual phototransduction;GPCR downstream signalling;Visual signal transduction: Cones
(Consensus)
Recessive Scores
- pRec
- 0.169
Intolerance Scores
- loftool
- 0.291
- rvis_EVS
- 1.56
- rvis_percentile_EVS
- 95.67
Haploinsufficiency Scores
- pHI
- 0.181
- hipred
- Y
- hipred_score
- 0.638
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.477
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gucy2f
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- cGMP biosynthetic process;protein phosphorylation;signal transduction;receptor guanylyl cyclase signaling pathway;visual perception;cGMP-mediated signaling;regulation of rhodopsin mediated signaling pathway;detection of light stimulus involved in visual perception
- Cellular component
- nuclear outer membrane;plasma membrane;integral component of plasma membrane;photoreceptor disc membrane
- Molecular function
- peptide receptor activity;guanylate cyclase activity;protein kinase activity;ATP binding;GTP binding;signaling receptor activity;protein homodimerization activity;protein heterodimerization activity